AICAR UK Research Compound for Advanced AMPK Applications
AICAR UK research compound is one of the most extensively studied AMPK-activating compounds within metabolic signalling, mitochondrial biology and exercise-mimetic research literature. At Lavish Peptides, we supply premium-quality AICAR products for laboratory and in vitro research applications throughout the United Kingdom and Europe, including London, Manchester, Birmingham, Liverpool, Leeds, Glasgow, Edinburgh, Dublin, Paris, Berlin, Amsterdam, Madrid, Milan and Rome.
AICAR, also known as Acadesine, AICA Riboside and 5-Aminoimidazole-4-carboxamide ribonucleoside, is a synthetic nucleoside analogue and intermediate within the purine biosynthesis pathway. Scientific investigations have identified AICAR as the defining pharmacological activator of AMP-activated protein kinase (AMPK) — the master cellular energy sensor regulating glucose uptake, fatty-acid oxidation and mitochondrial biogenesis.
Research literature has characterised AICAR as a cell-permeable AMP mimetic transported intracellularly via ENT1 nucleoside transporters and phosphorylated by adenosine kinase into ZMP (AICAR monophosphate), the active intracellular species responsible for AMPK activation. Published investigations documented that ZMP binds the γ-subunit of AMPK, promoting allosteric activation and sustained Thr172 phosphorylation by upstream kinases including LKB1.
Scientific investigations have additionally demonstrated that AICAR exerts broad downstream metabolic effects involving GLUT4 translocation, ACC phosphorylation, CPT1 activation, mTORC1 inhibition, PGC-1α upregulation and autophagy induction. Research literature further documented substantial endurance improvements and oxidative-fibre remodelling within sedentary animal models, establishing AICAR as one of the most important exercise-mimetic compounds in metabolic research history.
Each AICAR UK research vial supplied by Lavish Peptides is produced according to strict laboratory-focused standards and supplied as a lyophilised powder in sealed laboratory-grade vials designed to support product integrity during transport and storage. Every batch undergoes third-party HPLC and mass spectrometry analytical verification procedures to support high purity and consistency expectations for laboratory and analytical applications.
Researchers throughout England, Scotland, Ireland, Germany, France, Spain, Italy, the Netherlands, Belgium, Austria, Portugal and wider Europe increasingly seek trusted peptide and metabolic-compound suppliers capable of combining premium sourcing standards with dependable fulfilment procedures and discreet shipping services. Lavish Peptides continues supporting laboratories and metabolic researchers throughout the UK and Europe with premium research compounds and professional customer support.
Researchers interested in exploring additional premium peptide compounds can also browse our full peptide collection through the Lavish Peptides online catalogue.
Premium AICAR UK Laboratory Standards
At Lavish Peptides, quality assurance remains central to every product supplied throughout the UK and Europe. Every AICAR UK batch undergoes third-party HPLC and mass spectrometry verification procedures designed to support analytical purity and consistency expectations for laboratory and in vitro research use.
The compound is supplied within sealed amber laboratory vials intended to help minimise unnecessary environmental exposure during transport and storage. Orders are processed using discreet packaging and secure fulfilment procedures for customers throughout London, Manchester, Birmingham, Glasgow, Edinburgh, Paris, Berlin, Amsterdam, Madrid and Milan.
Researchers throughout England, Ireland, France, Germany, Spain and Italy continue seeking reliable peptide and metabolic-compound suppliers capable of delivering premium-quality AMPK research compounds with dependable shipping and transparent fulfilment standards. Lavish Peptides remains committed to supporting scientific researchers throughout Europe with premium laboratory compounds and responsive customer support.
As AMPK-signalling and mitochondrial-biology research continue expanding internationally, laboratories increasingly prioritise suppliers with strong quality-control standards and reliable fulfilment operations. Our objective is to provide premium research-compound sourcing for research-focused customers across the UK and European scientific market.
Scientific Interest in AICAR UK Research
AICAR UK research continues receiving substantial attention within biomedical-science literature and laboratory investigations involving AMPK activation, mitochondrial biogenesis and metabolic pathway analysis.
Research involving AICAR has discussed:
- AMPK γ-subunit activation
- Thr172 phosphorylation signalling
- GLUT4 translocation and glucose uptake
- ACC phosphorylation and CPT1 activation
- mTORC1 inhibition and anabolic suppression
- PGC-1α mitochondrial biogenesis
- ULK1 autophagy and mitophagy signalling
- Exercise-mimetic metabolic pathway investigations
Published scientific investigations have demonstrated that AICAR activates AMPK through intracellular conversion to ZMP, an AMP mimetic capable of allosterically activating the enzyme and protecting Thr172 from dephosphorylation. Research literature additionally documented enhanced glucose uptake and fatty-acid oxidation through downstream activation of GLUT4 translocation and inhibition of acetyl-CoA carboxylase.
Scientific literature has additionally confirmed that AICAR suppresses mTORC1 signalling through phosphorylation of TSC2 and Raptor while simultaneously promoting PGC-1α-mediated mitochondrial biogenesis and oxidative gene-expression programmes. Published studies therefore identified AICAR as the foundational pharmacological reference compound for AMPK biology and exercise-mimetic pathway research.
Several investigations have examined AICAR within endurance and skeletal-muscle research. A landmark study published in Cell demonstrated that four weeks of AICAR treatment in sedentary mice increased treadmill endurance by approximately 44% while simultaneously inducing oxidative-fibre remodelling and mitochondrial adaptation pathways.
Research literature has further explored AICAR within diabetic neuropathy, obesity and metabolic syndrome investigations. Published studies documented restoration of mitochondrial respiration, increased mitophagy signalling through ULK1 Ser555 phosphorylation and improvements in glucose tolerance within T1D and T2D animal models.
Scientific investigations additionally documented important AMPK-independent actions for AICAR involving purine biosynthesis interference, adenosine-pathway modulation and Akt/PI3K signalling activation. Research also explored applications within chronic lymphocytic leukaemia (CLL), stem-cell pluripotency, anti-doping assay development and cancer-cell metabolic stress research.
Research institutions and laboratories throughout London, Dublin, Berlin, Stockholm, Copenhagen, Vienna and Amsterdam continue exploring advanced metabolic compounds within controlled scientific environments. Interest in AMPK-activating compounds and mitochondrial-pathway research continues increasing throughout the UK and European scientific sector as laboratories seek advanced molecules for receptor and pathway analysis.
For researchers seeking additional peptide information and fulfilment experiences, our customer testimonials provide insight into the standards and customer experience offered by Lavish Peptides throughout the UK and Europe.
UK and European Research Compound Delivery
Lavish Peptides provides fast and discreet shipping for AICAR UK products throughout England, Scotland, Wales, Northern Ireland, Ireland, France, Germany, Spain, Italy, Belgium, Austria, Portugal, Sweden, Denmark, Poland and the Netherlands.
Researchers throughout London, Manchester, Liverpool, Birmingham, Leeds, Glasgow, Edinburgh, Paris, Berlin, Amsterdam, Madrid, Milan and Rome continue relying on secure fulfilment services and dependable delivery standards when sourcing laboratory compounds online.
Every AICAR UK order is packaged carefully to support customer privacy and maintain product integrity throughout transportation. Our fulfilment procedures are designed to support laboratories and research-focused customers seeking efficient research-compound sourcing across Europe.
Researchers interested in additional premium research compounds may also wish to explore our SLU-PP-332 peptide product available through the Lavish Peptides research catalogue.
Storage and Handling Recommendations
AICAR UK research products should be handled according to appropriate laboratory handling standards and storage procedures. Researchers commonly store lyophilised metabolic compounds in cool, dry environments away from direct sunlight and unnecessary temperature fluctuations.
Maintaining controlled storage conditions may help preserve product integrity during laboratory and analytical applications. Proper laboratory procedures should always be followed during preparation, handling and research activities.
Lavish Peptides recommends reviewing internal laboratory protocols and safe handling standards before working with research compounds within laboratory environments.
Why Researchers Choose Lavish Peptides
Lavish Peptides continues establishing itself as a trusted supplier within the UK and European peptide market by focusing on premium sourcing, third-party verification and professional fulfilment standards.
Researchers choose Lavish Peptides for:
- Premium research-grade sourcing
- Third-party HPLC-verified purity
- Fast UK dispatch
- Discreet packaging
- Reliable EU shipping
- Secure checkout experience
- Responsive customer support
- Laboratory-focused fulfilment standards
Our objective is to provide premium peptide compounds and metabolic research compounds for laboratory and analytical use throughout Europe while maintaining dependable customer support and strict quality expectations.
For laboratory and in vitro research use only. Not for human consumption. Not a medicine.
Reviews
There are no reviews yet.